Evidence map›Paper›PMID 34200325›Full record

ArticleInternational journal of molecular sciences2021

Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.

Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, Sandra Atlante, Luana Forleo, Marialisa Nesta, Massimo Massetti, Alfredo Pontecorvi, Simona Nanni, Antonella Farsetti and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07757620 (Epigenetic Changes in Long COVID Patients), which is not on this map. Cited by 79 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 4 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07757620 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Epigenetic Changes in Long COVID Patients: Unraveling the Gut-Immune Axis and Therapeutic Targets

TypeobservationalSponsorIstituti Clinici Scientifici Maugeri SpARan2026 to 2027Enrolled1,000ConditionsLong COVID-19 Syndrome, Long COVID Symptoms
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 4 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. NADCommunications biology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Alessia MongelliLaboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.ORCID 0000-0002-1262-3446
Veronica BarbiLaboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.ORCID 0000-0001-9618-1368
Michela Gottardi ZamperlaLaboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.
Sandra AtlanteLaboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.
Luana ForleoLaboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.
Marialisa NestaFoundation "Policlinico Universitario A. Gemelli IRCCS", Department of Translational Medicine & Surgery, Faculty of Medicine, and Department of Cardiovascular Science, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Massimo MassettiFoundation "Policlinico Universitario A. Gemelli IRCCS", Department of Translational Medicine & Surgery, Faculty of Medicine, and Department of Cardiovascular Science, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Alfredo PontecorviFoundation "Policlinico Universitario A. Gemelli IRCCS", Department of Translational Medicine & Surgery, Faculty of Medicine, and Department of Cardiovascular Science, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Simona NanniFoundation "Policlinico Universitario A. Gemelli IRCCS", Department of Translational Medicine & Surgery, Faculty of Medicine, and Department of Cardiovascular Science, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Antonella FarsettiInstitute for Systems Analysis and Computer Science "A. Ruberti" (IASI), National Research Council (CNR), 00185 Rome, Italy.ORCID 0000-0002-8603-7925
Oronzo CatalanoCardiac Rehabilitation Unit, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.
Maurizio BussottiCardiorespiratory Rehabilitation Department, IRCCS Maugeri Clinical Scientific Institutes, 20097 Milan, Italy.
Laura Adelaide Dalla VecchiaCardiorespiratory Rehabilitation Department, IRCCS Maugeri Clinical Scientific Institutes, 20097 Milan, Italy.ORCID 0000-0002-6516-0959
Tiziana BachettiScientific Direction, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100 Pavia, Italy.ORCID 0000-0003-1612-5329
Fabio MartelliLaboratory of Molecular Cardiology, Policlinico San Donato IRCCS, San Donato Milanese, 20097 Milan, Italy.ORCID 0000-0002-8624-7738
Maria Teresa La RovereScientific Direction, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100 Pavia, Italy.ORCID 0000-0002-1884-5058
Carlo GaetanoLaboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100 Pavia, Italy.
Istituti Clinici Scientifici Maugeri · ITUniversità Cattolica del Sacro Cuore · ITIRCCS Policlinico San Donato · ITNational Research Council · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 22858Fondazione Telethon 23054Fondazione Telethon 446 GGP19035AHorizon 2020 101016072Ministero della Salute RF 2010-2318330Ministero della Salute "RicercaCorrente" and "Progetto di Rete Cardiovascolare IRCCS: CardioCovid"Ministero dell'Educazione, Università e ricerca PRIN2017S55RXBMinistero dell'Istruzione, dell'Università e della Ricerca PRIN2015HPMLFY
6 · The paper itself

Abstract

The SARS-CoV-2 infection determines the COVID-19 syndrome characterized, in the worst cases, by severe respiratory distress, pulmonary and cardiac fibrosis, inflammatory cytokine release, and immunosuppression. This condition has led to the death of about 2.15% of the total infected world population so far. Among survivors, the presence of the so-called persistent post-COVID-19 syndrome (PPCS) is a common finding. In COVID-19 survivors, PPCS presents one or more symptoms: fatigue, dyspnea, memory loss, sleep disorders, and difficulty concentrating. In this study, a cohort of 117 COVID-19 survivors (post-COVID-19) and 144 non-infected volunteers (COVID-19-free) was analyzed using pyrosequencing of defined CpG islands previously identified as suitable for biological age determination. The results show a consistent biological age increase in the post-COVID-19 population, determining a DeltaAge acceleration of 10.45 ± 7.29 years (+5.25 years above the range of normality) compared with 3.68 ± 8.17 years for the COVID-19-free population (

Indexed as

CpG IslandsTelomere ShorteningAdultAgedAgingAngiotensin-Converting Enzyme 2BiomarkersCOVID-19Dipeptidyl Peptidase 4DNA MethylationEpigenomicsFemaleHigh-Throughput Nucleotide SequencingHost Microbial InteractionsHumansMaleACE2 protein, humanAngiotensin-Converting Enzyme 2BiomarkersDipeptidyl Peptidase 4ACE2biological ageCOVID-19DeltaAgeDNA methylationDPP-4epigeneticspost-COVID-19telomeres

Identifiers

PMID34200325
PMCPMC8201243
OpenAlexW3170500831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.